Biotech

All Articles

Rivus articles information to support muscle-sparing being overweight drug claims

.Rivus Pharmaceuticals has introduced the information responsible for its phase 2 being overweight g...

BMS pays $110M to create T-cell treatment deal, helping Top purchase time to improve prioritized pipeline

.Bristol Myers Squibb is actually paying for Prime Medicine $110 million upfront to create reagents ...

Generate gains an additional $1B-plus Significant Pharma partnership

.Novartis has actually inked a package potentially worth more than $1 billion along with Flagship-fo...

Metsera GLP-1 information slice reveals 7.5% fat loss at 36 times

.Just recently debuted Metsera is unfolding some stage 1 record for its own GLP-1 receptor agonist, ...

Flagship wishes biotechs group to Mirai to boost genetic medications

.In the middle of the hereditary medicines arms ethnicity, Crown jewel Pioneering is introducing a b...

BioAge eyes $180M from IPO, personal placement for excessive weight trials

.BioAge Labs is considering all around $180 thousand in preliminary proceeds from an IPO and also an...

Merck's LAG-3 combo neglects colorectal cancer cells period 3 study

.A try by Merck &amp Co. to open the microsatellite stable (MSS) metastatic intestines cancer cells ...

Spanish VC finalizes $200M life sciences fund

.Spain-based Asabys Partners has actually finalized a fund of 180 thousand euros ($ 200 million), fu...

BioAge produces $198M from IPO as obesity biotech joins Nasdaq

.BioAge Labs is actually generating nearly $200 thousand through its own Nasdaq IPO today, along wit...

Acadia delivers BMS vet on board as chief executive officer-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant management hirings, firings an...